Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 26 May 2026 for Karyopharm Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleGaren G. Bohlin
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Garen G. Bohlin: trading record in brief
This profile gathers the share dealings of Garen G. Bohlin across 2 companies, led by Collegium Pharmaceutical, Inc and Karyopharm Therapeutics Inc. We count 9 filings; the first trade dates from 6 May 2021 and the latest from 21 May 2026.
No open-market sale appears; the market trades are 2 purchases worth €72k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 2 option exercises.
On 26 May 2026 came the latest disclosure, a share grant in Karyopharm Therapeutics Inc. The last purchase on record was published on 12 September 2023, which is 1,132 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Garen G. Bohlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
15,508 shares0Common StockSEC:0001254705-26-000008:0
8,700 shares@ US$16.490.0083% mcap100.0% of flowCommon StockSEC:0001254705-26-000002:0
9,791 shares0Common StockSEC:0001062993-25-009808:0
28,985 shares@ US$5.7355.8% of flowCommon StockSEC:0001062993-24-010536:0
41,140 shares@ US$1.21547.3% of flowCommon StockSEC:0000950170-23-047712:0
Canonical exit: 11 Dec 2023 (T+90)
9,792 shares0Common StockSEC:0001062993-23-011813:0
14,035 shares0Common StockSEC:0001062993-22-013300:0
9,941 shares0Common StockSEC:0001192482-21-000453:0
4,000 shares@ US$7.8235.8% of flowCommon StockSEC:0001209191-21-031437:0
Canonical exit: 4 Aug 2021 (T+90)
9 of 9 declarations
